6124
H. Akpınar et al. / Polymer 51 (2010) 6123e6131
also investigated as a green to transmissive polymer with red shifted
absorptions compared to BTd derivative [14]. Recently, introduction
ofBTzunitsonPEDOTresultedintheenhancementofelectrochromic
properties such as optical contrast, switching time and coloration
efficiencycompare toparentpolymerPEDOT[15]. Although, BTd, BSe
and BTz based polymers and their different copolymers have been
studied extensively in literature, DAD type electrochromic polymers
with BIm as the acceptor unit are still unexplored up to date. Instead,
benzimidazoles which are an important molecule in vitamin B12
have been widely used in biological applications. It was shown that
they have antibacterial, virucidal and antitumor properties [16].
Polybenzimidazoles on the other hand showed great thermal
stability and resistance to high temperatures [17].
In this report, we highlight the synthesis and optoelectronic
properties of BIm based DAD type polymers containing EDOT as the
donor unit. Substituent effect on electrochemical and optical
properties was investigated. Substitution of benzene and EDOT
units on 2-C position of BIm resulted in two homologue polymers.
Additionally, ferrocene (Fc) incorporation as pendant group was
expected to reveal different redox behaviors due to its reversible
and well defined electrochemical signal. Electrochromic properties
of polymers were also compared with their different acceptor unit
analogues where EDOT is the donor unit, to have a better under-
standing on acceptor unit effect.
2.2.2. 4-(2,3-Dihydrothieno[3,4-b][1,4]dioxin-5-yl)-7-(2,3-
dihydrothieno[3,4-b][1,4]dioxin-7-yl)-2-benzyl-1H-benzo[d]
imidazole (M1)
In a three necked round-bottom flask fitted with a condenser
and argon inlet, 4,7-dibromo-2-phenyl-1H-benzo[d]imidazole
(100 mg, 0.28 mmol) and tributyl(2,3-dihydrothieno[3,4-b][1,4]
dioxin-7-yl)stannane (490 mg, 1.14 mmol) were dissolved in 25 ml
of dry THF. After 30 min stirring under argon flow, dichlorobis
(triphenyl phosphine)palladium(II) (30 mg, 0.027 mmol) was
added at room temperature. The mixture was left to reflux for 18 h.
Solvent was evaporated under vacuum and the crude product was
purified by column chromatography over silica gel 1:2 (ethyl-
acetate:hexane) to obtain M1 as yellow solid (78 mg, yield: 58.7%).
1H (400 MHz, CDCl3,
(m, 3H), 7.42 (d, 1H), 6.52 (s, 1H), 6.44 (s, 1H), 4.48 (d, 2H), 4.38 (d,
4H), 4.29 (d, 2H). 13C NMR (100 MHz, CDCl3,
): 150.4, 142.0, 141.5,
d): 10.61 (s, 1H), 8.09 (d, 2H), 8.05 (d, 1H), 7.50
d
141.1, 139.5, 135.9, 131.5, 130.2, 129.9, 129.0, 128.2, 126.4, 125.3,
123.9, 121.3, 120.7, 116.7, 114.6, 114.5, 100.9, 99.2, 65.6, 64.9, 64.5,
64.4. MS (m/z): 475 [Mþ].
2.2.3. 2,4-Bis(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-7-(2,3-
dihydrothieno[3,4-b][1,4]dioxin-7-yl)-1H-benzo[d]imidazole (M2)
This monomer was prepared with the same procedure
described for M1 using 4,7-dibromo-2-(2,3-dihydrothieno[3,4-b]
[1,4]dioxin-5-yl)-1H-benzo[d]imidazole (200 mg, 0.48 mmol),
tributyl(2,3-dihydrothieno[3,4-b][1,4]dioxin-7-yl)stannane
2. Experimental section
(829.1 mg, 1.92 mmol), and dichlorobis(triphenyl phosphine)
palladium(II) (50 mg, 0.045 mmol) in 35 ml of dry THF. After
removing the solvent on rotary evaporator, the residue was sub-
jected to column chromatography on silica gel, eluting with 1:1
(ethyl acetate:hexane) to obtain M2 as yellow solid (156 mg, yield:
2.1. General
All chemicals were purchased from commercial sources and
used without further purification. All reactions were carried out
under argon atmosphere unless otherwise mentioned. 4,7-
Dibromobenzothiadiazole [18], 3,6-dibromobenzene-1,2-diamine
[19], tributyl(2,3-dihydrothieno[3,4-b][1,4]dioxin-7-yl)stannane
[20], 2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbaldehyde [7],
4,7-dibromo-2-phenyl-1H-benzo[d]imidazole [11a] and 4,7-
dibromo-2-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-1H-benzo
[d]imidazole [11a] were synthesized according to previously
published procedures. Electrochemical studies were performed in
a three-electrode cell consisting of an Indium Tin Oxide doped
glass slide (ITO) as the working electrode, platinum wire as the
counter electrode, and Ag wire as the pseudo reference electrode
under ambient conditions using a Voltalab 50 potentiostat. 1H and
13C NMR spectra were recorded in CDCl3 on Bruker Spectrospin
Avance DPX-400 Spectrometer. Chemical shifts were given in ppm
downfield from tetramethylsilane. Varian Cary 5000 UVeVis
spectrophotometer was used to perform the spectroelec-
trochemical studies of polymers. Mass analysis was carried out on
a Bruker time-of flight (TOF) mass spectrometer with an electron
impact ionization source.
60.3%).1H (400 MHz, CDCl3,
d
): 10.86 (s, 1H), 8.02 (d, 1H), 7.38 (d,
1H), 6.50 (s, 1H), 6.49 (s, 1H), 6.43 (s, 1H), 4.36 (m, 12H). 13C NMR
(100 MHz, CDCl3, ): 145.2, 143.9, 140.9, 140.3, 139.7, 139.2, 135.5,
d
129.1, 127.3, 124.6, 120.5, 119.7, 114.9, 114.1, 110.3, 107.9, 101.9, 101.3,
98.7, 64.7, 64.6, 64.3, 63.3, 63.2. MS (m/z): 539 [Mþ].
2.2.4. 4-(2,3-Dihydrothieno[3,4-b][1,4]dioxin-5-yl)-7-(2,3-
dihydrothieno[3,4-b][1,4]dioxin-7-yl)-2-ferrocenyl-1H-benzo[d]
imidazole (M3)
This compound was also prepared with the same procedure
described above, using 4,7-dibromo-2-ferrocenyl-1H-benzo[d]
imidazole (500 mg, 1.08 mmol), tributyl(2,3-dihydrothieno[3,4-b]
[1,4]dioxin-7-yl)stannane (829.1 mg, 1.92 mmol), and dichlorobis
(triphenyl phosphine)palladium(II) (70 mg, 0.064 mmol) in 50 ml
of dry THF. In this case completion of the reaction was achieved by
an additional 30 h of reflux as monitored by TLC. Solvent was
removed under vacuum and the crude product was purified by
column chromatography over silica gel 1:3 (ethylacetate:hexane) to
obtain M3 as orange solid (430 mg, yield: 68%). 1H (400 MHz,
DMSO-d6,
(s, 1H), 5.22 (t, 2H), 4.48 (t, 2H), 4.39 (m, 4H), 4.28 (m, 4H), 4.14
(s, 5H). 13C NMR (100 MHz, DMSO-d6,
): 152.7, 142.2, 141.3, 140.1,
d): 11.69 (s, 1H), 7.92 (d,1H), 7.09 (d,1H), 6.75 (s,1H), 6.69
2.2. Synthesis
d
139.1, 138.4, 132.4, 124.3, 122.0, 121.5, 119.1, 113.8, 112.6, 100.7, 98.8,
79.3, 79.1, 78.9, 78.6, 74.2, 69.8, 69.4, 67.9, 67.8, 64.8, 64.6, 64.2, 64.0,
56.0. MS (m/z): 583 [Mþ].
2.2.1. 4,7-Dibromo-2-ferrocenyl-1H-benzo[d]imidazole (3c)
3,6-Dibromobenzene-1,2-diamine (500 mg, 1.88 mmol) and fer-
rocenecarboxaldehyde (483 mg, 2.41 mmol) were dissolved in 30 ml
methanol (MeOH). After clear solution was obtained, 20 mg iodine
were added to the mixture and stirred at room temperature over-
night. Subsequent precipitate was filtered and washed with cold
MeOH(3ꢀ 50ml). The product wasobtained asorangesolid (530mg,
yield: 77%) after re-crystallization in MeOH. 1H (400 MHz, DMSO-d6,
3. Results and discussions
3.1. Synthesis
Synthesis of electroactive donoreacceptoredonor (DAD) type
monomers was achieved as shown in Scheme 1. Bromination of
benzothiadiazole was performed with Br2 in HBr to give the 4,7-
dibromobenzothiadiazole (2) in very high yields (98%) [18].
d
): 12.80 (s,1H), 7.30 (m, 2H), 5.26 (t, 2H), 4.53 (t, 2H), 4.15 (s, 5H). 13
NMR (100 MHz, DMSO-d6, ): 155.4, 142.9, 134.8, 133.3, 132.1, 125.4,
125.3, 110.1, 105.6, 101.7, 101.6, 99.5, 79.1, 72.8, 70.3, 69.5, 68.0.
C
d